These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 3435101)

  • 1. Effect of quinolones and other antimicrobial agents on cell-associated Legionella pneumophila.
    Havlichek D; Saravolatz L; Pohlod D
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1529-34. PubMed ID: 3435101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WIN 57273 is bactericidal for Legionella pneumophila grown in alveolar macrophages.
    Edelstein PH; Edelstein MA
    Antimicrob Agents Chemother; 1989 Dec; 33(12):2132-6. PubMed ID: 2619277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory and bactericidal activities of levofloxacin, ofloxacin, erythromycin, and rifampin used singly and in combination against Legionella pneumophila.
    Baltch AL; Smith RP; Ritz W
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1661-6. PubMed ID: 7486896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells.
    Stout JE; Arnold B; Yu VL
    Diagn Microbiol Infect Dis; 1998 Jan; 30(1):37-43. PubMed ID: 9488830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibacterial activity in vitro of 10 quinolones against 20 strains of Legionella pneumophila].
    Deforges L; Fournet MP; Soussy CJ; Duval J
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):631-3. PubMed ID: 3534757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of levofloxacin, erythromycin or rifampicin pretreatment on growth of Legionella pneumophila in human monocytes.
    Smith RP; Baltch AL; Franke M; Hioe W; Ritz W; Michelsen P
    J Antimicrob Chemother; 1997 Nov; 40(5):673-8. PubMed ID: 9421315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Legionella pneumophila multiplication within human macrophages by antimicrobial agents.
    Vildé JL; Dournon E; Rajagopalan P
    Antimicrob Agents Chemother; 1986 Nov; 30(5):743-8. PubMed ID: 3492176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular multiplication of Legionnaires' disease bacteria (Legionella pneumophila) in human monocytes is reversibly inhibited by erythromycin and rifampin.
    Horwitz MA; Silverstein SC
    J Clin Invest; 1983 Jan; 71(1):15-26. PubMed ID: 6848556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Legionella pneumophila multiplication within human macrophages by fleroxacin.
    Pohlod DJ; Saravolatz LD; Somerville MM
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():49-54. PubMed ID: 3144549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-gamma and antibiotics fail to act synergistically to kill Legionella pneumophila in human monocytes.
    Bhardwaj N; Horwitz MA
    J Interferon Res; 1988 Jun; 8(3):283-93. PubMed ID: 3137275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of DNA probes to antimicrobial susceptibility testing of Legionella pneumophila.
    Reznicek M; Bale M; Pfaller M
    Diagn Microbiol Infect Dis; 1991; 14(1):7-10. PubMed ID: 2013212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic susceptibility of Legionella pneumophila strains isolated in England and Wales 2007-17.
    Wilson RE; Hill RLR; Chalker VJ; Mentasti M; Ready D
    J Antimicrob Chemother; 2018 Oct; 73(10):2757-2761. PubMed ID: 30053025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial activities of gemifloxacin, levofloxacin, gatifloxacin, moxifloxacin and erythromycin against intracellular Legionella pneumophila and Legionella micdadei in human monocytes.
    Baltch AL; Bopp LH; Smith RP; Michelsen PB; Ritz WJ
    J Antimicrob Chemother; 2005 Jul; 56(1):104-9. PubMed ID: 15941776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of Legionella pneumophila to ofloxacin in vitro and in experimental Legionella pneumonia in guinea pigs.
    Saito A; Sawatari K; Fukuda Y; Nagasawa M; Koga H; Tomonaga A; Nakazato H; Fujita K; Shigeno Y; Suzuyama Y
    Antimicrob Agents Chemother; 1985 Jul; 28(1):15-20. PubMed ID: 3862361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of gatifloxacin, compared with ciprofloxacin, clarithromycin, erythromycin, and rifampin, against Legionella species.
    Dubois J; St-Pierre C
    Diagn Microbiol Infect Dis; 1999 Apr; 33(4):261-5. PubMed ID: 10212753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activities of tigecycline and comparators against Legionella pneumophila and Legionella micdadei extracellularly and in human monocyte-derived macrophages.
    Bopp LH; Baltch AL; Ritz WJ; Michelsen PB; Smith RP
    Diagn Microbiol Infect Dis; 2011 Jan; 69(1):86-93. PubMed ID: 21146719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Legionella pneumophila in guinea pig peritoneal macrophages by new quinolone, macrolide and other antimicrobial agents.
    Kitsukawa K; Hara J; Saito A
    J Antimicrob Chemother; 1991 Mar; 27(3):343-53. PubMed ID: 2037540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of sparfloxacin (CI-978; AT-4140) for clinical Legionella isolates, pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumonia.
    Edelstein PH; Edelstein MA; Weidenfeld J; Dorr MB
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2122-7. PubMed ID: 2073101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic susceptibility of Legionella pneumophia Philadelphia-1 in cultured guinea-pig peritoneal macrophages.
    Yoshida S; Mizuguchi Y
    J Gen Microbiol; 1984 Apr; 130(4):901-6. PubMed ID: 6736922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic Susceptibility of Environmental
    Cocuzza CE; Martinelli M; Perdoni F; Giubbi C; Vinetti MEA; Calaresu E; Frugoni S; Scaturro M; Ricci ML; Musumeci R
    Int J Environ Res Public Health; 2021 Sep; 18(17):. PubMed ID: 34501942
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.